CIK 0000872589 · Large accelerated filer
REGENERON PHARMACEUTICALS, INC.
Sign in to watch- Ticker
- REGN
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- NY
- Entity type
- operating
- EIN
- 133444607
- Phone
- 9148477000
- Business address
- 777 OLD SAW MILL RIVER ROAD, TARRYTOWN, NY, 10591
- Former names
- REGENERON PHARMACEUTICALS INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $51,901,544
- in 11 filings, $8.6M under 10b5-1 plans
Net −$51,901,544. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-08-13 | MURPHY ANDREW J EVP Research | Shares withheld for taxes 10b5-1 | −13,637 | $1,141.49 | $15.6M | 54,669 |
| 2024-08-13 | MURPHY ANDREW J EVP Research | Option exercise · Non-Qualified Stock Option (right to buy) 10b5-1 | −20,000 | 0 | ||
| 2024-08-13 | STAHL NEIL EVP Research and Development | Gift 10b5-1 | −500 | 49,599 | ||
| 2024-08-12 | STAHL NEIL EVP Research and Development | Gift 10b5-1 | −900 | 50,099 | ||
| 2024-08-08 | STAHL NEIL EVP Research and Development | Sale 10b5-1 | −100 | $1,081.83 | $108K | 56,096 |
| 2024-08-08 | STAHL NEIL EVP Research and Development | Sale 10b5-1 | −200 | $1,082.69 | $217K | 55,896 |
| 2024-08-08 | STAHL NEIL EVP Research and Development | Sale 10b5-1 | −1,006 | $1,083.76 | $1.1M | 54,890 |
| 2024-08-08 | STAHL NEIL EVP Research and Development | Sale 10b5-1 | −1,883 | $1,084.61 | $2.0M | 53,007 |
| 2024-08-08 | STAHL NEIL EVP Research and Development | Sale 10b5-1 | −1,708 | $1,085.01 | $1.9M | 51,299 |
| 2024-08-08 | STAHL NEIL EVP Research and Development | Sale 10b5-1 | −300 | $1,086.15 | $326K | 50,999 |
| 2024-08-07 | Pitofsky Jason VP Controller | Option exercise | +487 | $372.46 | $181K | 4,691 |
| 2024-08-07 | Pitofsky Jason VP Controller | Sale | −487 | $1,070.00 | $521K | 4,204 |
| 2024-08-07 | Pitofsky Jason VP Controller | Option exercise · Non-Qualified Stock Option (right to buy) | −487 | 0 | ||
| 2024-08-02 | STAHL NEIL EVP Research and Development | Option exercise | +23,638 | $555.67 | $13.1M | 74,637 |
| 2024-08-02 | STAHL NEIL EVP Research and Development | Shares withheld for taxes | −18,441 | $1,093.49 | $20.2M | 56,196 |
| 2024-08-02 | STAHL NEIL EVP Research and Development | Option exercise · Non-Qualified Stock Option (right to buy) | −23,638 | 45,000 | ||
| 2024-08-02 | Bassler Bonnie L Director | Option exercise 10b5-1 | +756 | $371.40 | $281K | 2,138 |
| 2024-08-02 | Bassler Bonnie L Director | Sale 10b5-1 | −756 | $1,115.00 | $843K | 1,382 |
| 2024-08-02 | Bassler Bonnie L Director | Option exercise · Non-Qualified Stock Option (right to buy) 10b5-1 | −756 | 2,272 | ||
| 2024-08-01 | RYAN ARTHUR F Director | Sale 10b5-1 | −1 | $1,100.03 | $1K | 17,782 |
Page 21 of 49 · 971 trades